ArticleProtein engineering, design & selection : PEDS2026
Rapid selection of high-affinity DARPins using click display.
Article in Protein engineering, design & selection : PEDS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rapid and scalable protein binder discovery platforms are essential for accelerating therapeutic and diagnostic development. Click display is a cell-free protein display technology that covalently links nascent proteins to their encoding cDNA in a one-pot reaction within 2 h, enabling rapid in vitro selection. Although previously demonstrated to support directed evolution, enrichment efficiency during biopanning was slower than conventional phage display. Here, we report two modifications that significantly enhance click display selection efficiency: (i) selective elution of target-bound complexes using a cleavable biotin linker, and (ii) competitive displacement of non-specific bead binders using a biotinylated blocking protein. These improvements dramatically reduce amplification of non-specific binders and enable efficient enrichment of target-specific binders within three to four rounds of panning. Using a naïve DARPin library, we rapidly enriched binders to interleukin-10 (IL-10) and transforming growth factor-β1 (TGF-β1), identifying clones with low nanomolar binding affinities and receptor-blocking activity. We further applied the optimized protocol to affinity maturation of a PD-L1-binding DARPin, achieving >400-fold improved binding affinity. The best candidate, 1D10, exhibits sub-nanomolar PD-1 inhibition in competition ELISA. These results demonstrate that the optimized click display workflow enables rapid enrichment and affinity maturation of high-affinity DARPins across diverse targets. The platform provides a streamlined, transformation-free approach for accelerating protein engineering and directed evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.